Synthesis of [(13)N]cisplatin Journal Article


Authors: Haber, M. T.; Cooper, A. J. L.; Rosenspire, K. C.; Ginos, J. Z.; Rottenberg, D. A.
Article Title: Synthesis of [(13)N]cisplatin
Abstract: A method for the “carrier‐added” synthesis of [13N]cisplatin is described. Yields were ∼1–4 mCi from 20–40 mCi of [13N]ammonia with a total synthesis time of 19–28 minutes. The product was ∼96% radiochemically pure as judged by HPLC analysis and had a specific activity of ∼100 mCi/mmole in 1.0 ml of saline. [13N]Cisplatin was administered intraperitoneally to mice. Of the tissues investigated, concentration of label was highest in kidneys. At 10 min, considerable label in the blood, liver, and kidney was in a form other than cisplatin. However, no evidence was obtained that [13N]ammonia was released from [13N]cisplatin in vivo. [13N]Cisplatin may be used to assess drug delivery to primary and metastatic brain tumors in patients receiving intravenous or intraarterial cisplatin chemotherapy. Copyright © 1985 John Wiley & Sons, Ltd.
Keywords: nonhuman; mouse; animal experiment; drug synthesis; liver; kidney; drug distribution; brain; drug tissue level; drug monitoring; drug blood level; high performance liquid chromatography; radioisotope; pharmacokinetics; muscle; nervous system; drug identification; intraperitoneal drug administration; priority journal; preliminary communication; blood and hemopoietic system; drug analysis; cisplatin n 13; [13n]ammonia; [13n]cisplatin
Journal Title: Journal of Labelled Compounds and Radiopharmaceuticals
Volume: 22
Issue: 5
ISSN: 0362-4803
Publisher: Wiley Blackwell  
Date Published: 1985-05-01
Start Page: 509
End Page: 516
Language: English
DOI: 10.1002/jlcr.2580220512
PROVIDER: scopus
DOI/URL:
Notes: Note -- Export Date: 26 October 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. James Z. Ginos
    15 Ginos
Related MSK Work